Page last updated: 2024-12-08

2'-deoxymugineic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2'-deoxymugineic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID189811
CHEBI ID19274
SCHEMBL ID1059538
MeSH IDM0149923

Synonyms (20)

Synonym
2'-deoxymugineic acid
(2s)-1-[(3s)-3-carboxy-3-{[(3s)-3-carboxy-3-hydroxypropyl]amino}propyl]azetidine-2-carboxylic acid
74235-24-8
CHEBI:19274
2'-dma
1-azetidinebutanoic acid, 2-carboxy-alpha-((3-carboxy-3-hydroxypropyl)amino)-, (2s-(1(alphar*(r*)),2r*))-
(13c4)-2'-deoxymugineic acid
1-azetidinebutanoicacid, 2-carboxy-a-[[(3s)-3-carboxy-3-hydroxypropyl]amino]-,(as,2s)-
SCHEMBL1059538
AKOS030242921
2 inverted exclamation mark -deoxymugineic acid
1-{3-carboxy-3-[(3-carboxy-3-hydroxypropyl)amino]propyl}azetidine-2-carboxylic acid
DTXSID50995715
Q27109156
(2s)-1-[(3s)-3-carboxy-3-[[(3s)-3-carboxy-3-hydroxypropyl]amino]propyl]azetidine-2-carboxylic acid
(2~{s})-1-[(3~{s})-3-[[(3~{s})-3,4-bis(oxidanyl)-4-oxidanylidene-butyl]amino]-4-oxidanyl-4-oxidanylidene-butyl]azetidine-2-carboxylic acid
CS-0186017
2 inverted exclamation marka-deoxymugineic acid
HY-W127849
(s)-1-((s)-3-carboxy-3-(((s)-3-carboxy-3-hydroxypropyl)amino)propyl)azetidine-2-carboxylic acid

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Iron bioavailability in unleavened white and wholegrain bread made from two commercial wheat varieties was assessed by measuring ferritin production in Caco-2 cells."( Iron bioavailability in two commercial cultivars of wheat: comparison between wholegrain and white flour and the effects of nicotianamine and 2'-deoxymugineic acid on iron uptake into Caco-2 cells.
Eagling, T; Fairweather-Tait, SJ; Shewry, PR; Wawer, AA; Zhao, FJ, 2014
)
0.6
" Biofortification is a micronutrient intervention aimed at increasing the density and bioavailability of essential vitamins and minerals in staple crops; Fe biofortification of wheat has proved challenging."( Metabolic engineering of bread wheat improves grain iron concentration and bioavailability.
Beasley, JT; Bonneau, JP; Callahan, DL; Glahn, RP; Johnson, AAT; Lombi, E; Moreno-Moyano, LT; Sánchez-Palacios, JT; Tako, E, 2019
)
0.51
" Nicotianamine (NA) is a natural chelator of Fe, zinc (Zn) and other metals in higher plants and NA-chelated Fe is highly bioavailable in vitro."( Nicotianamine-chelated iron positively affects iron status, intestinal morphology and microbial populations in vivo (Gallus gallus).
Beasley, JT; Bonneau, JP; Glahn, RP; Johnson, AAT; Kolba, N; Koren, O; Ozeri, L; Tako, E, 2020
)
0.56
"Iron (Fe) is an essential nutrient, but is poorly bioavailable because of its low solubility in alkaline soils; this leads to reduced agricultural productivity."( Development of a mugineic acid family phytosiderophore analog as an iron fertilizer.
Aung, MS; Chiba, Y; Fujino, H; Fukushima, K; Kanaki, M; Kobayashi, K; Kobayashi, T; Masuda, H; Mera, A; Mukaiyama, H; Murata, Y; Nakanishi, H; Nakayama, A; Namba, K; Nishio, S; Nishizawa, NK; Sasaki, S; Shrestha, BB; Suzuki, M; Takeuchi, M; Tanino, K; Tsugawa, R; Urabe, A; Watanabe, T, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Response to iron deficiency1017
Mugineic acid biosynthesis214
Iron uptake and transport in root vascular system85

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.44)18.7374
1990's2 (4.88)18.2507
2000's11 (26.83)29.6817
2010's23 (56.10)24.3611
2020's4 (9.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.60 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (9.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (90.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]